找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Genome Editing in Cardiovascular and Metabolic Diseases; Junjie Xiao Book 2023 The Editor(s) (if applicable) and The Author(s), under excl

[復制鏈接]
樓主: arouse
31#
發(fā)表于 2025-3-27 00:52:05 | 只看該作者
32#
發(fā)表于 2025-3-27 02:38:11 | 只看該作者
33#
發(fā)表于 2025-3-27 05:22:00 | 只看該作者
https://doi.org/10.1007/978-981-10-6563-7ble to perform these types of experiments. Here, the different strategies for gene editing and their online tools are gathered, putting the light on its application in the study and treatment of cardiovascular and metabolic diseases.
34#
發(fā)表于 2025-3-27 10:41:09 | 只看該作者
Online Databases of Genome Editing in Cardiovascular and Metabolic Diseasesble to perform these types of experiments. Here, the different strategies for gene editing and their online tools are gathered, putting the light on its application in the study and treatment of cardiovascular and metabolic diseases.
35#
發(fā)表于 2025-3-27 17:08:51 | 只看該作者
Book 2023dology of genome editing. Genome editing is a genetic engineering technique precisely modified specific target genes of organism genome, which has been applied to basic theoretical research and production applications from plants and animals to gene therapy of human beings. Cardiovascular and metabo
36#
發(fā)表于 2025-3-27 19:30:59 | 只看該作者
37#
發(fā)表于 2025-3-28 00:38:52 | 只看該作者
38#
發(fā)表于 2025-3-28 02:17:55 | 只看該作者
E. Galán,R. Ca?ada,F. Fernández,B. Cerverasafety issues related to the once-and-done therapy focusing on CRISPR/Cas systems. We give an outlook on the potential gene targets prioritized by large-scale genetic studies of cardiovascular diseases and genome editing in precision medicine of dyslipidemia and atherosclerosis.
39#
發(fā)表于 2025-3-28 09:31:44 | 只看該作者
40#
發(fā)表于 2025-3-28 12:49:09 | 只看該作者
Genome Editing and Myocardial Developmentmodels are well-suited to study and predict clinical outcome. This review summarizes the anatomical and genetic timeline of myocardial development in both mice and humans, the potential of gene editing in typical CHD categories, as well as the use of mice thus far in reproducing models of human CHD and correcting the mutations that create them.
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-9 18:40
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
吴堡县| 临桂县| 浠水县| 民丰县| 张家川| 岳西县| 同德县| 西华县| 水城县| 咸宁市| 静海县| 汉阴县| 建阳市| 关岭| 阿瓦提县| 宝清县| 朝阳区| 平舆县| 仲巴县| 灌南县| 达州市| 泰州市| 东方市| 威远县| 嘉鱼县| 甘孜县| 西乌珠穆沁旗| 南靖县| 年辖:市辖区| 绥滨县| 福建省| 桦甸市| 渭源县| 永胜县| 信宜市| 南靖县| 宜黄县| 定州市| 桂东县| 武胜县| 保山市|